Get notified when TVTX files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TVTX Travere Therapeutics, Inc. 8-K

Travere Therapeutics reports Q1 2026 financial results

Filed May 4, 2026 · Period ending May 4, 2026 · ~1 min read

Key Changes

  • medium

    Company announced first quarter 2026 financial results through press release dated May 4, 2026. Specific financial metrics and performance details are contained in the attached exhibit.

    Item 2.02 verify on EDGAR →

This preview is just the start — the full report includes the narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (PXED 10-Q) is open in full — no account needed.

Partner

Trade TVTX commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?
View original filing on SEC.gov Press release (Ex 99.1) on EDGAR ↗

Source-verified from EDGAR · Narrative written by AI · Jun 3, 2026 · How we verify